REQUEST A DEMO
Total
USD $0.00
Search more companies

Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tibet Rhodiola Pharmaceutical Holding Co. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) is a company in China, with a head office in Guangzhou. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on July 14, 1999. Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) currently employs 596 (2024) people. In 2025, the company reported a net sales revenue increase of 6.23%. There was a total growth of 32.02% in Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司)’s total assets over the same period. The net profit margin of Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) decreased by 6.9% in 2025.

Headquarters
No. 3, Guangzhou Road, Area A, Lhasa Economic and Technological Development Zone, Lhasa, Lhasa, Tibet, No. 427, Sanse Road, Jinjiang District, Chengdu, Sichuan Province
Guangzhou; Guangdong; Postal Code: 850000

Contact Details: Purchase the Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) report to view the information.

Website: http://www.xzyy.cn

Basic Information
Total Employees:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) report to view the information.
Registered Capital:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) report to view the information.
Incorporation Date:
July 14, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
32.28%
Purchase this report to view the information.
17.42%
Purchase this report to view the information.
3.19%
Purchase this report to view the information.
3.11%
Purchase this report to view the information.
1.97%
Subsidiaries
Chengdu Nuodikang Biopharmaceutical Co., Ltd.
100%
Shanghai Xinhuo Biological Technology Co., Ltd.
100%
Sichuan Nuodi Kangweiguang Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Tibet Rhodiola Pharmaceutical Holding Co. (西藏诺迪康药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
6.23%
Total Operating Revenue
6.7%
Operating Profit
-10.05%
Net Profit/Loss for the Period
-13.25%
Total Assets
32.02%
Total Equity
4.69%
Operating Profit Margin
-6.34%
Net Profit Margin
-6.9%
Return on Equity (ROE)
-4.59%
Debt / Equity
12455%
Quick Ratio
-1765.03%
Cash Ratio
-0.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?